Natural Endocannabinoid Derivatives as Templates for the Development of FAAH Inhibitors

E-ISSN： 1875-628x|2|5|372-376

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.5, 2005-08, pp. : 372-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Partial QSAR Analysis of Some Selected Natural Inhibitors of FAAH Suggests a Working Hypothesis for the Development of Endocannabinoid- Based Drugs

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 6, 2005-01 ,pp. : 709-714

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of Endocannabinoid-Hydrolyzing Enzyme Inhibitors

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-06 ,pp. : 828-858

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoid Transporter Inhibitors

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 2, 2002-06 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat

By Cippitelli Andrea Cannella Nazzareno Braconi Simone Duranti Andrea Tontini Andrea Bilbao Ainhoa DeFonseca Fernando Piomelli Daniele Ciccocioppo Roberto

Psychopharmacology, Vol. 198, Iss. 4, 2008-07 ,pp. : 449-460

Springer Publishing Company

Access to resources Recommend Favorite

Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors

By Marzo O.D. Petrocellis L.D. Bisogno T.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 2, 2001-04 ,pp. : 241-265

Informa Healthcare

Access to resources Recommend Favorite